Last update Oct23

Abbvie Inc. (2021). HIGHLIGHTS OF PRESCRIBING INFORMATION. http://www.fda.gov/medwatch.

Cantudo-Cuenca, M. R., Robustillo-Cortés, M. A., Cantudo-Cuenca, M. D., & Morillo-Verdugo, R. (2014). A better regulation is required in viral hepatitis smartphone applications. Farmacia Hospitalaria : Organo Oficial de Expresion Cientifica de La Sociedad Espanola de Farmacia Hospitalaria38(2), 112–117. http://www.ncbi.nlm.nih.gov/pubmed/24669895

CDA Foundation. (2023). CDA Foundation 2023 Global HCV Statistics. https://cdafound.org/polaris/

CDC. (2020a). Hepatitis C Testing ServicesApril, 1–12. https://www.cdc.gov/hepatitis/hcv/HepatitisCTesting.htm

CDC. (2020b, July 28). Definition of Hepatitis C. https://www.cdc.gov/hepatitis/hcv/cfaq.htm

Creative Commons. (2023). Creative Commons. https://creativecommons.org/

EMA. (2017). Maviret | European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/maviret

FDA. (2017). FDA approves Mavyret for Hepatitis C | FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-mavyret-hepatitis-c

Grebely, J., Dore, G. J., Morin, S., Rockstroh, J. K., & Klein, M. B. (2017). Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there. Journal of the International AIDS Society20(1). https://doi.org/10.7448/IAS.20.1.22146

Health, G., Strategy, S., Ending, T., & Hepatitis, V. (2021). Viral hepatitis 2016–2021June 2016.

hepatitisfoundation. (n.d.). hepatitis-c. https://www.hepatitisfoundation.org.nz/liver-disease/hepatitis/hepatitis-c

Jae Young Jang5, and D. Y. K. H. W. L. H. L. B. K. K. Y. C. (2022). Cost-effectiveness of chronic hepatitis C screening and treatment. Clinical and Molecular Hepatology28(16), 164–173. https://doi.org/10.3350/cmh.2021.0193

Kim, D. Y., Yoon, K. T., Kim, W., Lee, J. Il, Hong, S. H., Lee, D., Jang, J. W., Choi, J. W., Kim, I., & Paik, Y. H. (2016). Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea. Medicine95(30). https://doi.org/10.1097/MD.0000000000003896

Lazarus, L., Patel, S., Shaw, A., Leblanc, S., Lalonde, C., Hladio, M., Mandryk, K., Horvath, C., Petrcich, W., Kendall, C., & Tyndall, M. W. (2016). Uptake of community-based peer administered HIV point-of-care testing: Findings from the PROUD study. PLoS ONE11(12), 1–11. https://doi.org/10.1371/journal.pone.0166942

Muncan, B., Walters, S. M., Ezell, J., & Ompad, D. C. (2020). “they look at us like junkies”: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduction Journal17(1), 1–9. https://doi.org/10.1186/s12954-020-00399-8

Paquette, C., Syvertsen, J., & Pollini, R. (2018). 乳鼠心肌提取 HHS Public Access. Physiology & Behavior176(5), 139–148. https://doi.org/10.4049/jimmunol.1801473

Schwander, B., Feldstein, J., Sulo, S., Gonzalez, L., ElShishiney, G., & Hassany, M. (2022). Pursuing Elimination of Hepatitis C in Egypt: Cost-Effectiveness and Economic Evaluation of a Country-Wide Program. Infectious Diseases and Therapy11(3), 1193–1203. https://doi.org/10.1007/s40121-022-00631-x

Spradling, P. R., Richardson, J. T., Buchacz, K., Moorman, A. C., Finelli, L., Bell, B. P., & Brooks, J. T. (2010). Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996–2007. JAIDS Journal of Acquired Immune Deficiency Syndromes53(3), 388–396. https://doi.org/10.1097/QAI.0b013e3181b67527

The Hepatitis Fund. (2023). The Hepatitis Fund. https://endhep2030.org/

Villena, E. Z. (2006). Transmission routes of hepatitis C virus infection. Annals of Hepatology5(SUPPL. 1), 12–14.

VMLY&R. (2022). Hep C AUDIENCE, HEALTH PROVIDER AND NEEDLE EXCHANGE INSIGHTS REPORT. https://acrobat.adobe.com/link/review?uri=urn:aaid:scds:US:248ed2e0-b7b4-394d-9146-4676944dd52d

WHO. (2016). Global health sector strategy on viral hepatitis 2016-2021. Global Hepatitis Programme Department of HIV/AIDSJune, 56. https://apps.who.int/iris/handle/10665/246177

WHO. (2021). Tracking Universal Health Coverage: 2021 Global Monitoring Report. In Tracking Universal Health Coverage: 2017 Global Monitoring Report. https://doi.org/10.1596/978-92-4-151355-5

World Bank. (2015). New WHO and World Bank Group Report Shows that 400 Million Do Not Have Access to Essential Health Services and 6% of Population Tipped into or Pushed Further into Extreme Poverty because of Health Spending. https://www.worldbank.org/en/news/press-release/2015/06/12/new-who-and-world-bank-group-report-shows-that-400-million-do-not-have-access-to-essential-health-services-and-6-of-population-tipped-into-or-pushed-further-into-extreme-poverty-because-of-health-

Zelenev, A., Li, J., Shea, P., Hecht, R., & Altice, F. L. (2021). Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States. Clinical Infectious Diseases72(5), 755–763. https://doi.org/10.1093/cid/ciaa142